Post-Golgi Vesicles Cotransport Docosahexaenoyl-Phospholipids and Rhodopsin during Frog Photoreceptor Membrane Biogenesis*

(Received for publication, September 19, 1996, and in revised form, December 30, 1996)

Elena B. Rodriguez de Turco Dagger , Dusanka Deretic §, Nicolas G. Bazan Dagger and David S. Papermaster par

From the Dagger  LSU Neuroscience Center and Department of Ophthalmology, Louisiana State University Medical Center, School of Medicine, New Orleans, Louisiana 70112, the § University of Michigan, Departments of Ophthalmology and Anatomy and Cell Biology, Ann Arbor, Michigan 48105, and par  Univeristy of Texas, Health Science Center, Department of Pathology, San Antonio, Texas 78284-7750

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Post-Golgi vesicles budding from the trans-Golgi network (TGN) are involved in the vectorial transport and delivery of rhodopsin to photoreceptor rod outer segments (ROS). We report here that newly synthesized docosahexaenoyl (DHA) phospholipids are sequestered and cotransported by rhodopsin-bearing post-Golgi vesicles to ROS. Frog retinas were pulse-labeled with [35S]methionine/cysteine and [3H]DHA prior to ROS isolation and subcellular fractionation. After a 1-h pulse, relatively uniform [3H]DHA-lipid labeling (DPM/µg protein) was observed in all fractions enriched in post-Golgi vesicles, TGN, Golgi, and endoplasmic reticulum (ER) membranes. During the subsequent 2-h chase translocation of free [3H]DHA from ROS to the photoreceptor inner segment contributed to an additional overall increase in labeling of lipids. The specific activity (dpm/nmol DHA) in ER-enriched fraction was similar or higher than in other subcellular fractions after both the pulse and the chase, indicating that the bulk of [3H]DHA-lipids was synthesized in the ER. After the chase a 2-fold increase in labeling of lipids in the ER and Golgi and a 2.6-fold in lighter TGN-enriched fractions was observed. The highest labeling was in the post-Golgi vesicle fraction (4-fold increase), with [3H]DHA-phosphatidylcholine and [3H]DHA-phosphatidylethanolamine showing the greatest increase. At the same time, newly synthesized [35S]rhodopsin shifted from the ER and Golgi toward TGN and post-Golgi fractions. Therefore, sequestration and association of [35S]rhodopsin and [3H]DHA-lipids in a TGN membrane domain occurs prior to their exit and subsequent vectorial cotransport on post-Golgi vesicles to ROS. Labeling of ROS lipids was very low, with phosphatidylinositol and diacylglycerols displaying the highest labeling. This indicates that other mechanisms by-passing Golgi, i.e. facilitated by lipid carrier proteins, may also contribute to molecular replacement of disc membrane DHA-phospholipids, particularly phosphatidylinositol.


INTRODUCTION

Vertebrate photoreceptors are polarized and compartmentalized cells, with a photosensitive outer segment and a synaptic terminal domain at opposite ends of the cell. These domains are attached through a connecting cilium and a short axon, respectively, to a central region, the inner segment. The inner segment is the site where lipid and protein synthesis, polarized sorting of molecules, and initiation of membrane biogenesis for both the outer segment and synaptic terminals take place. Disc membranes in rod outer segments (ROS)1 display a unique lipid-protein composition. The visual pigment rhodopsin, which accounts for more than 85% of disc membrane proteins (1), is embedded within a highly fluid lipid bilayer comprised of phospholipids (PLs) highly enriched in docosahexaenoic acid (DHA, 22:6n-3) (2-6).

Amphibian photoreceptor cells are a useful experimental model to study protein and lipid trafficking in a polarized cell. Photoreceptors actively synthesize proteins (mainly rhodopsin) and DHA-PLs to support the dynamic daily renewal of 50-80 large disc membranes in each rod cell that results in the addition of membrane at sime 3 µm2/min (7, 8). ROS lack the capacity for de novo synthesis of PLs (4, 9). Therefore, they depend entirely on an external supply of PLs from the inner segment where they are synthesized mainly in the rough endoplasmic reticulum (ER) (10). How these highly unsaturated lipids become components of ROS membranes and at which stage of membrane biosynthesis and disc morphogenesis they become associated with rhodopsin is not yet clear.

Newly synthesized rhodopsin is vectorially transported from its site of synthesis in the rough ER to ROS by vesicles that bud from the trans-Golgi network (TGN), cluster beneath the connecting cilium, and fuse with the inner segment plasma membrane within the periciliary ridge complex (11, 12). A very low buoyant density (rho  = 1.09 g/ml) post-Golgi vesicular subcellular fraction carrying newly synthesized rhodopsin has been isolated and characterized from frog retinal photoreceptor cells (12-15). Whereas rhodopsin and the bulk of DHA-PLs are synthesized in the rough ER and both can follow a vesicle-mediated traffic through the biosynthetic pathway, other mechanisms can contribute to trafficking and selective delivery of PLs to intracellular organelles (16-18). For example, the rapid monomer transport of PLs is facilitated by transfer proteins (TP) through the cytosol (19). A transfer protein that with high affinity transfers PC to ROS membranes has also been described (20), and immunohistochemical analysis of chicken retinas at hatching revealed the presence of phosphatidylinositol (PI)-TP in retinal cells including the inner segment of photoreceptors (21).

Phospholipid renewal of ROS membranes involves both membrane replacement (as new disc membranes are assembled at the base of the ROS) and molecular replacement (i.e. PL transfer protein mediated and remodeling of disc PLs by turnover) (22, 23). Using various radiolabeled lipid precursors under experimental conditions that inhibit protein synthesis or vesicle-mediated transport, lipids can be transported to ROS by independent pathways by-passing the Golgi (24-28). However sorting of DHA-PLs, vectorial transport to ROS, and the contribution of alternative pathways to their trafficking has not been experimentally addressed. This question is especially intriguing because biochemical and autoradiographic studies of [3H]DHA trafficking in frog photoreceptors after in vitro (29, 30) and in vivo (31, 32) labeling have disclosed that newly synthesized [3H]DHA-PLs display a polarized delivery to ROS, where they are incorporated at the base as new discs are formed, in a pattern paralleling incorporation of radiolabeled amino acids into disk membrane proteins.

The aim of the current study was to investigate if newly synthesized DHA-lipids could be, at least in part, segregated and cotransported with rhodopsin in vesicles budding from the TGN and then enter the ROS as new membranes are formed (membrane replacement). To address this question, we pulse-labeled frog retinas for 1 h in the presence of [3H]DHA and [35S]methionine/cysteine, followed by a 2-h chase in a cold buffer prior to subcellular fractionation (12, 33). [3H]DHA was chosen because this precursor is actively esterified into PLs in the inner segment of photoreceptor (34-38) prior to their vectorial transport to the ellipsoid region at the base of ROS and also to synaptic terminals (29, 30). Our results reveal that newly synthesized [3H]DHA-PLs, especially the main components of disc membranes (i.e. DHA-phosphatidylcholine (PC) and DHA-phosphatidylethanolamine (PE)), are segregated and loaded together with newly synthesized [35S]rhodopsin in post-Golgi vesicles. Some lipids, i.e. [3H]DHA-PI and [3H]DHA-diacylglycerols (DAG), are very rapidly synthesized and delivered to ROS probably by alternative pathways that by-pass the Golgi and may be facilitated by carrier proteins.


EXPERIMENTAL PROCEDURES

Frogs, Rana berlandieri (100-250 g), were purchased from Rana Co. (Brownsville, TX), maintained in a 12-h light/12-h dark cycle, and fed crickets for a week prior to the experiment. [4, 5-3H]DHA (specific activity 17 Ci/mmol) and [35S]Express protein labeling mixture (1,000 Ci/mmol) were from DuPont NEN. High performance thin layer chromatographic plates (10 × 10 cm, 150 µm thickness) were from Analtech (Newark, DE). Lipids and fatty acid methyl ester standards and protease inhibitors were from Sigma. High performance liquid chromatography grade solvents were from EM Science (Gibbstown, NJ). All other reagents used were of the highest purity available.

In Vitro Labeling of Retinal Lipids and Proteins with [3H]DHA and [35S]Methionine/Cysteine

Retinas recovered from frog eyecups 2 h before the time of light offset were dissected and subsequently incubated under dim red light. Two sets of 21 retinas were incubated in 30 ml of an oxygenated medium as described (14, 35) at 22 °C in the presence of [3H]DHA (5.7 µCi/retina, final DHA concentration 0.24 µM), and [35S]Express protein labeling mixture (25 µCi/retina) for 1 h. One set of retinas was further incubated for 2 h in cold buffer containing unlabeled amino acids (pulse-chase samples) prior to subcellular fractionation. Since the in vitro retinal metabolism of [3H]DHA is altered at µM DHA concentrations (29, 30, 39), cold DHA was not added during the chase. Therefore, this chase period will hereafter be identified as "chase" to reflect this condition.

Rod Outer Segments Isolation and Retinal Subcellular Fractionation

All the procedures followed for the isolation of ROS and subcellular fractionation have been described in detail elsewhere (12, 33). Briefly, following the pulse and pulse-chase labeling, retinas were sheared through a 14-gauge needle, and ROS were separated by flotation on 34% sucrose. Retinal pellets were rehomogenized in 0.25 M sucrose in 10 mM Tris acetate, pH 7.4, containing 1 mM MgCl2 and centrifuged for 4 min at 4,000 rpm (1250 gav, JA20 rotor, Beckman Instruments, Inc., Palo Alto, CA). The postnuclear supernatant (3 ml) recovered after this centrifugation is enriched in photoreceptor biosynthetic membranes and organelles involved in rhodopsin transport (12, 33). To isolate post-Golgi vesicles from TGN, Golgi, and ER membranes, the postnuclear supernatant was overlaid on a 10-ml linear 20-39% (w/w) sucrose gradient in 10 mM Tris acetate buffer, pH 7.4, containing protease inhibitors and 1 mM MgCl2, above a 0.5-ml cushion of 49% (w/w) sucrose in the same buffer. Gradients were centrifuged for 13 h at 4 °C in a SW40 rotor (Beckman) at 28,000 rpm (100,000 gav). Fourteen fractions (0.9 ml each) were reproducibly collected from the top of the gradient. A Buchler Auto Densi-Flow fractionator was used to prepare the gradient and to collect the fractions. The subcellular fractions were diluted 4-fold with 10 mM Tris-HCl and pelleted at 50,000 rpm (240,000 gav) for 40 min in a SW50 rotor. The pellets were resuspended in 210 µl of Tris acetate, pH 7.4, and divided into two aliquots, one-third for protein analysis and two-thirds for lipid analysis.

Protein Analysis

SDS-polyacrylamide gel electrophoresis was performed as described previously (12). 35S-Labeled rhodopsin was determined in subcellular fractions by exposure of dried SDS gels to storage phosphor screens, and the intensity of luminescence associated with the rhodopsin band was measured and analyzed by a PhosphorImager densitometer (Molecular Dynamics). Total proteins were quantified according to Fanger (40), using bovine serum albumin as a standard.

Lipid Extraction and Analysis

Lipids were extracted from the fractions by adding 3 ml of chloroform:methanol (2:1, v/v) following the Folch procedure (41). Individual phospholipids and neutral lipids were isolated in the same TLC plate following a two-dimensional, three-step TLC procedure (6) as follows: an aliquot of the labeled lipid extract containing phospholipid and neutral lipid standards as a carriers was applied on the lower right corner (1.5 cm from each border) of 10 × 10 cm high performance thin layer chromatography plates previously sprayed with 3% magnesium acetate and activated for at least 1 h at 100 °C. The plate was developed in the first dimension twice using the Rouser I chromatographic system (chloroform/methanol/ammonia, 65:25:5, v/v) until the solvent front reached 2 cm from the top of the plate. After drying with cold air, the plate was turned to the right 90°, and neutral lipid standards (cholesterol ester, triacylglycerol, diacylglycerol, and monoacylglycerol) were spotted 1.5 cm from the bottom and 0.5 cm from the right border. Plates were then developed in hexane/ether (60:40, v/v) to isolate individual neutral lipids that had accumulated at the front of the first chromatographic system. The silica gel was cut with a vertical line to isolate neutral lipid (right) from phospholipid (left) areas of the plate (approximately 3 cm from the right border), and the silica was scraped off from the bottom right corner prior to running the plates in the Rouser II system (chloroform/acetone/ methanol/acetic acid, 30:40:10:10:5, v/v). This third chromatographic step, run in the same direction as the second step, allows the isolation of individual phospholipid classes and free fatty acids that run with the solvent front above PE. Lipid spots were visualized by iodine staining, and the radioactivity was determined in a Beckman scintillation counter.

Aliquots of lipid extracts were taken for gas-liquid chromatography analysis of endogenous fatty acid content and composition. Fatty acid methyl esters were prepared in glass tubes by transmethylation with 2 ml of toluene/methanol/sulfuric acid (100:100:4, v/v) for 4 h at 65 °C, after flushing the tubes with nitrogen and capping with a Teflon-lined cap. The tubes were cooled at room temperature, and 1 ml of water, 3 ml of hexane, and a mixture of two internal standards (17:0 and 21:0 methyl esters) were added. Fatty acid methyl esters resuspended in hexane were separated onto a SP-2330 column (30 m, 0.25 mm inner diameter, 0.2-µm film thickness, Suppelco, Bellefonte, PA) by using helium as a carrier gas, in a Varian Vista 401 gas chromatograph (Palo Alto, CA). The injector and detector temperatures were 220 and 250 °C, respectively, and the column temperature was programmed from 70 to 230 °C (42). The peaks were detected by flame ionization, identified by comparison with the retention times of authentic fatty acid methyl esters standard, and quantified using the internal standards.

Statistical Analysis

Values for [3H]DHA lipid labeling and [35S]rhodopsin are presented as a mean ± S.E. for n = four individual experiments. Data were compared using Student's t test for pair samples. A p value of < 0.05 was considered statistically significant.


RESULTS

Post-Golgi Vesicles Are Enriched with Newly Synthesized [35S]Rhodopsin and [3H]DHA-Lipids

To determine whether newly synthesized [3H]DHA-PLs and [35S]rhodopsin are transported together in the same population of post-Golgi vesicles recovered in fraction 5 of the sucrose gradient, retinas were pulse-labeled for 1 h in the presence of both precursors and further incubated for 2 h (chase) in cold buffer prior to subcellular fractionation. This experimental protocol gives sufficient labeling of newly synthesized rhodopsin within 1-h pulse and a maximum labeling of the vesicles (fraction 5) during the following 2-h chase (12, 43). While the total [35S]rhodopsin labeling recovered from the combined 14 fractions was similar for pulse and chase samples (data not shown), total esterified [3H]DHA was increased by 2.6 ± 0.2-fold: from 1.2 × 106 dpm/21 retinas after a 1-h pulse to 3.2 × 106 dpm/21 retinas after a 2-h chase. After 1 h of pulse labeling, 58% of total [35S]rhodopsin was recovered in TGN and Golgi (fractions 7-11) (Fig. 1) as expected (12). After a 2-h "chase," a shift toward post-Golgi fractions 4-6 was observed, with fraction 5 displaying the greatest increase (ratio chase/pulse: 2.4 ± 0.5). The profile of total esterified [3H]DHA among subcellular fractions was similar to that of [35S]rhodopsin (Fig. 1), with the highest percent values observed in those fractions that also accumulated the largest proportion of membranes (Fig. 2D). Remarkably after the 2-h chase only post-Golgi fraction 5 displayed significantly higher [3H]DHA percent labeling (ratio chase/pulse, 1.7 ± 0.2) at the time when newly synthesized [35S]rhodopsin accumulated in this fraction. Simultaneously, percent labeling in fractions 12 and 13 was lower than during the pulse.


Fig. 1. Newly synthesized [3H]DHA-lipids and [35S]rhodopsin exit the TGN in very low buoyant density vesicles recovered in the sucrose density gradient fraction 5. Twenty-one frog retinas were incubated for 1 h with [3H]DHA and [35S]methionine/cysteine followed by a 2-h chase in cold buffer containing unlabeled amino acids. Aliquots were taken from each fraction recovered after pulse and chase labeling for lipid and protein analysis. Lipids were extracted and isolated by TLC. Esterified [3H]DHA was estimated after subtraction of the free [3H]DHA from total labeling. Proteins were separated by SDS-gel electrophoresis, and the radioactivity incorporated into [35S]rhodopsin was determined by a PhosphorImager densitometer. Mean values ± S.E. from n = four separate experiments are shown and represent the percent distribution of total labeling recovered from the 14 fractions of the gradient. S.E. are shown when the range is larger than the symbol. Asterisk denotes values that are significantly different from pulse labeling (p < 0.05, Student's t test). C, cytosol; PG, post-Golgi vesicles; TGN, trans-Golgi network; G, Golgi; ER, endoplasmic reticulum.
[View Larger Version of this Image (32K GIF file)]



Fig. 2. [3H]DHA-lipids attain a relatively uniform labeling in all fractions after a 1-h pulse. After a 2-h chase newly synthesized lipids accumulate in fractions containing post-Golgi vesicles recovered in fraction 5. Lipid labeling was normalized to protein content of individual subcellular fractions and shown as a mean value in dpm/µg protein ± S.E. (n = 4). A, free [3H]DHA was isolated from phospholipids and neutral lipids by a two-dimensional, three-step TLC as detailed under "Experimental Procedures." B, total esterified [3H]DHA is the sum of [3H]DHA found esterified into phospholipids and neutral lipids. C, the ratio of chase/pulse labeling of total [3H]DHA esterified into lipids. D, protein content of individual subcellular fractions. Mean values ± S.E. from n = 8 determinations including all the pulse and chase samples are shown. Other details as in Fig. 1 legend.
[View Larger Version of this Image (23K GIF file)]


Labeling recovered from individual subcellular fractions based upon protein content is shown in Fig. 2 and reveals four features. First, after a 1-h pulse, all fractions displayed similar labeling of esterified [3H]DHA (Fig. 2B). Second, after the subsequent 2-h "chase," labeling of DHA-lipids increased at least 2-fold in the heavy fractions that correspond to the density of ER (13-14), Golgi (11-12), and TGN (10), by 2.6-fold in lighter TGN fractions 7-9, and peaking at 4-fold higher labeling in post-Golgi vesicles recovered in fraction 5 as compared with pulse-labeled values (Fig. 2, B-C). Third, no significant difference between pulse and chase labeling was observed in the free [3H]DHA pool, indicating an equilibrium between the arrival of the precursor to these membrane compartments and its esterification into lipids either by de novo synthesis and/or turnover (Fig. 2A). The peak of labeling observed in fraction 8 may be the result of free [3H]DHA contributed by a small proportion of heavily labeled ROS cosedimenting between fractions 7 and 9 at a buoyant density of 1.13 g/ml (12). Fourth, most of the label recovered from ROS after pulse and chase labeling was found as free DHA (92 ± 1 and 76 ± 1%, respectively) (Fig. 2A), whereas ROS lipids labeling was the lowest among all subcellular fractions analyzed (Fig. 2B). A 2.5-fold increase in ROS [3H]DHA-lipids labeling after the "chase" (from 138 ± 25 to 350 ± 40 dpm/µg protein) accounted for by the concomitant loss of only 15% of free [3H]DHA (from 2600 to 1160 dpm/µg protein).

The specific activity of total [3H]DHA-lipids (dpm/nmol of endogenous DHA content) showed that fraction 14 (ER) displayed, after both the pulse (2790 ± 245 dpm/nmol DHA) and the "chase" (5060 ± 840 dpm/nmol DHA) labeling, similar or higher values than other fractions. After the pulse labeling, the specific activity of fraction 5 (1990 ± 115 dpm/nmol DHA) was significantly lower than that of fraction 14 (p < 0.05). After the chase, the specific activity of fraction 5 increased 3-fold (6580 ± 550 dpm/nmol DHA) but was not significantly different from the specific activity of fraction 14 (p > 0.19).

Phosphatidylcholine, Phosphatidylethanolamine, and Phosphatidylinositol Are Highly Labeled in All Subcellular Fractions; [3H]DHA-PC and [3H]DHA-PE Preferentially Shift toward Post-Golgi Vesicles (Fraction 5) after the Chase

The two most abundant PLs in retinal membranes, PC and PE, reveal a similar labeling profile after a 2-h "chase" (Fig. 3). [3H]DHA-PC and [3H]DHA-PE gradually increased from fractions enriched in ER to heavy fractions of the TGN, with a sharp peak in post-Golgi fraction 5 reaching a 5.2- and 4.6-fold increase, respectively, above pulse labeling. The profile of [3H]DHA-PI was very similar to that of [3H]diacylglycerol (DAG), and their labeling was significantly increased only in TGN fractions 7-9, with the highest increase in post-Golgi fraction 5 (3.9- and 2.5-fold, respectively). PS was the only phospholipid that did not show a peak of labeling in fraction 5 but displayed 3-fold increase between fractions 5 and 7. Phosphatidic acid (PA) labeling gradually increased from ER fractions to post-Golgi fraction 5 with no significant differences from the 1-h pulse labeling.


Fig. 3. [3H]DHA-PC and [3H]DHA-PE are the phospholipids that display the highest increase of labeling in rhodopsin bearing post-Golgi vesicles after the chase. Total dpm recovered in individual lipids per µg protein are shown. Insets, labeling of ROS lipids (dpm per µg of protein) after pulse (open bars) and chase (closed bars). Other details as in Fig. 1 legend.
[View Larger Version of this Image (53K GIF file)]


[3H]DHA-PL labeling in ROS was very low (Fig. 3, insets) with a different pattern of distribution than all other subcellular fractions (Fig. 4). Although the small amount of ROS that is recovered in the gradient between fraction 7 and 9 may contribute to their highly free [3H]DHA labeling (Fig. 2), it cannot contribute to but rather results in an underestimation of lipid labeling in these fractions that arise from inner segment membranes. [3H]DHA-PI displayed, by far, the highest labeling in ROS, with a 7.9-fold increase after a 2-h "chase," followed by DAG (4.8-fold), PC, and PS (3-fold each). No differences were observed between a 1-h pulse and 2-h "chase" labeling in [3H]DHA-PE and [3H]DHA-PA (Fig. 3, insets). This short-term incubation may reflect the labeling of disc membrane lipids by molecular replacement including (a) [3H]DHA incorporation by turnover, (b) the fast transport from the inner segment of a portion of newly synthesized [3H]DHA-lipids (i.e. [3H]DHA-PI), and/or (c) further metabolism of newly incorporated [3H]DHA-PLs into ROS such as N-methylation of [3H]DHA-PE to [3H]DHA-PC (4, 44).


Fig. 4. [3H]DHA-PI, [3H]DHA-PC, and [3H]DHA-PE display the highest percent labeling in all retinal subcellular fractions except for ROS which show the highest labeling in [3H]DHA-PI and [3H]DHA-DAG. Values represent percent labeling of individual lipids with respect to total [3H]DHA recovered esterified into lipids. Other details as Fig. 1 legend.
[View Larger Version of this Image (40K GIF file)]


The percent distribution of esterified [3H]DHA displayed high values for PI, PC, and PE in all fractions except for ROS (Fig. 4). In fraction 5 they reached a similar value (28%), although in other fractions, PI labeling alone prevailed. The highest percent labeling of PI was observed in fraction 1 (48%) and to a lesser extent in fraction 2 (34%), probably associated with cytosolic proteins recovered at the top of the gradient that may sediment after the 40,000 centrifugation (12). The ratio PI to PC labeling was higher in TGN fractions as compared with post-Golgi fractions 4-6, showing the highest value in fraction 8 of the TGN after both pulse and chase labeling (Fig. 5).


Fig. 5. Lipids from TGN fraction 8 display the highest [3H]DHA-PI/[3H]DHA-PC ratio. Upper panel, values represent percent labeling of PI and PC with respect to total esterified [3H]DHA recovered in lipids from individual subcellular fractions. Lower panel, ratios of percent [3H]DHA-PI/[3H]DHA-PC after pulse and chase labeling. Other details as Fig. 1 legend.
[View Larger Version of this Image (24K GIF file)]


The Content of Endogenous Fatty Acyl Chains of Lipids from Post-Golgi Vesicular Fractions

Total fatty acyl group content, reflecting mainly membrane phospholipids, increased gradually from the heaviest, ER-enriched fractions (2 nmol/µg protein) to the post-Golgi light vesicular fractions 4-5 (4 nmol/µg protein) (Fig. 6). The endogenous DHA content was very similar for all fractions (approximately 20% of total acyl groups) except for TGN fractions 7-9 where ROS, not completely removed prior to subcellular fractionation, cosedimented. In ROS, DHA accounted for 50% of total acyl groups. The lower % DHA content in fraction 5 as compared with ROS suggests that either the lipids from the vesicles bearing rhodopsin are less enriched in DHA-lipid and/or that lipids contributed by other vesicles with a lower degree of unsaturation are recovered in this fraction. The latter possibility is unlikely since immunoisolation of rhodopsin-bearing post-Golgi vesicles with anti-rhodopsin antibody indicated that they constitute >85% of the vesicles sedimenting in fraction 5 of the gradient (12). The net amount of DHA per protein in ROS (1.93 nmol/µg) was twice that of lipids from fraction 5 vesicles (0.85 nmol/µg protein). Although rhodopsin is the most abundant protein recovered in fraction 5, its contribution to the total proteins in the fraction is less than 50%, whereas rhodopsin accounts for 85-90% of total ROS proteins (12). Therefore, the net amount of DHA-PLs with respect to rhodopsin protein in these post-Golgi vesicles may reach values similar to that of ROS.


Fig. 6. Lipids from post-Golgi vesicle fraction 5 display a similar content of lipid-acyl groups but a lower content of DHA as compared with ROS membranes. An aliquot of lipid extracts was derivatized to fatty acid methyl esters, and their content and acyl group composition was analyzed by GLC as detailed under "Experimental Procedures." The observed higher content of DHA in fractions 7-8 is probably due to their contamination with ROS membranes. Mean values ± S.E. from n = 8-10 individual determinations are shown and expressed as nmol of fatty acids/µg of protein. Inset, mol % content of DHA in subcellular fractions.
[View Larger Version of this Image (31K GIF file)]



DISCUSSION

This study provides the first available information about the closely coordinated trafficking, sorting, and association of newly synthesized [3H]DHA-PLs with [35S]rhodopsin in frog photoreceptors as the two major membrane components initiate their journey from the rough ER, where they are synthesized, move through the Golgi, and leave the TGN on post-Golgi vesicles vectorially driven to ROS for the assembly of new disc membranes. Our results also yield several other important findings: (a) free [3H]DHA may be incorporated by turnover in disc PLs although much less efficiently than when utilized in the inner segment for [3H]DHA-PLs synthesis; (b) some [3H]DHA-PLs, mainly [3H]DHA-PI, are actively synthesized in the inner segment, rapidly transported to ROS, and incorporated into disc membranes; (c) during the short period of in vitro labeling (1-3 h), the fast labeling of all disc membranes by molecular replacement (i.e. protein-mediated transport of [3H]DHA-PLs and/or [3H]DHA incorporation by turnover) as compared with the labeling of a few discs at the base by membrane replacement, makes it difficult to assess the contribution of the latter mechanism to the overall labeling of ROS lipids.

The time course of [35S]rhodopsin labeling through the different compartments of the secretory pathway reflects its vesicle-mediated vectorial traffic from the site of synthesis at the rough ER to only one destination, ROS. The well defined early accumulation of [35S]rhodopsin in Golgi fractions by 1 h of labeling followed by its displacement during the subsequent 2-h chase toward TGN and post-Golgi vesicles recovered in fraction 5 (14 and Fig. 1) was used as a marker of membrane flow to follow the fate of newly synthesized [3H]DHA-lipids. Labeled lipids recovered in Golgi and TGN-enriched fractions at any time represent newly synthesized lipids that become constitutive components of the membranes as well as the different [3H]DHA-lipid pools that are in transit through these compartments to different destinations. [3H]DHA-lipids labeling of post-Golgi vesicles (fraction 5), however, is a clear indication of those newly synthesized [3H]DHA-lipids cotransported with [35S]rhodopsin to ROS.

Within the first hour of pulse labeling, [3H]DHA incorporation into lipids reached similar values in all subcellular fractions. This rapid equilibrium [3H]DHA-lipids among all fractions was also reflected in a similar mol % content of endogenous DHA (20%). Only fractions 7-9, contaminated with ROS membranes, displayed higher mol % values. Thus, newly synthesized [3H]DHA-lipids were rapidly transported throughout the multiple compartments of the biosynthetic pathway either by vesicle budding and fusion, by carrier proteins, and/or by lateral diffusion through intermembrane bridges (17, 18). Incorporation of [3H]DHA by turnover in lipids trafficking along the transport pathway could also contribute to the uniform labeling distribution observed among subcellular fractions.

After the 2-h "chase" labeling in cold buffer, it became apparent that the high labeling of free [3H]DHA in ROS was not paralleled by an efficient esterification into disc membrane phospholipids but rather by a translocation to the inner segment where it was actively esterified. This could be accomplished by the presence of (a) DHA-fatty acid binding proteins in ROS (45) and in the cytosolic fraction of retinas (46, 47) and (b) DHA-CoA synthetase in microsomes. This enzyme that activates DHA prior to its esterification into lipids displays the highest activity in microsomes from frog retinas and very low activity in ROS (48). Although free DHA can be incorporated in disc membrane PLs by turnover of their acyl groups (49-51), our present results indicate that the bulk of DHA is incorporated into lipids in the inner segment prior to their delivery to ROS (52). Indeed, the similar or higher specific activity of total [3H]DHA-lipids observed in the ER-enriched fractions as compared with other fractions enriched in membranes of the Golgi and post-Golgi supports this notion.

An interesting observation after the 2-h cold chase incubation was that the increase in [3H]DHA-lipids labeling was not of the same magnitude for all subcellular fractions (Figs. 2 and 3). It showed a clear trend from a 2-fold increase in ER and Golgi, to 2.5-fold in TGN, and the highest 4-fold increase in post-Golgi vesicles (gradient fraction 5). Because these fractions also became heavily labeled with newly synthesized [35S]rhodopsin after the chase, it appears that some newly synthesized [3H]DHA-PLs are sorted, along with newly synthesized [35S]rhodopsin in transit toward the TGN exit. The highest [3H]DHA-PLs labeling observed in [35S]rhodopsin-bearing post-Golgi vesicles suggests that they budded from microdomains in the TGN enriched in both [3H]DHA-PLs and [35S]rhodopsin. In fact, rhodopsin shows a preference for association with more fluid lipids (53), and in ROS PLs with high DHA content are in closer association with rhodopsin than less unsaturated ones (54). That the highest [3H]DHA-PLs labeling in post-Golgi vesicles observed after the 2-h "chase" could be the result of differences in lipid turnover in this fraction is unlikely since (a) labeling gradually increased from Golgi to post-Golgi vesicles, (b) no differences in the specific activity (total [3H]DHA-PLs/endogenous DHA content) between post-Golgi vesicles and ER fraction was observed, and (c) after 1-h pulse labeling post-Golgi vesicles did not show higher labeling than other fractions. Taken together these data strongly argue in favor of a progression of label through a series of compartments. Moreover, the similar [3H]DHA-lipid labeling observed after 1 h among all subcellular fractions also suggests an early association between newly synthesized DHA-lipids and newly synthesized rhodopsin rather than with older rhodopsin molecules already moving ahead in transit through the Golgi.

The profile of individual [3H]DHA-lipids labeling in subcellular fractions after the 2-h "chase" was very similar for the two main membrane components PE and PC, which also displayed the highest increase of labeling in post-Golgi vesicles (Fig. 3). This observation and the very low labeling of [3H]DHA-PC and [3H]DHA-PE recovered in ROS (Figs. 3 and 4) suggests that their incorporation into disc membranes mainly occurs by membrane replacement. Our preliminary studies using brefeldin A, which perturbs rhodopsin trafficking, show that [3H]DHA-PL and [35S]rhodopsin transfer into fraction 5, PE and PC, in particular, were successfully blocked, and also that ROS lipid labeling was reduced.2 At difference with PE and PC, [3H]DHA-PI displayed a more sustained increase throughout TGN peaking in post-Golgi fracton 5. Although the labeling of [3H]DHA-DAG was much lower than that of [3H]DHA-PI (Fig. 4), both followed a very similar profile (Fig. 3), probably reflecting an active phosphodiesteratic catabolism of PI with the consequent generation of labeled DAG along the TGN compartment. In ROS, [3H]DHA-DAG and [3H]DHA-PI displayed the highest labeling (Fig. 4), suggestive of their active translocation and incorporation in disc membranes by molecular replacement. Several lines of experimental evidence appear to indicate that PI, synthesized de novo in the inner segment of photoreceptors, can actively be transferred to ROS by-passing the Golgi (24, 28). In ROS, PI can be further phosphorylated to phosphatidylinositol 4,5-bisphosphate (9, 55). Because ROS contains a light-stimulated phosphoinositide-specific phospholipase C (56, 57), the presence of a photoreceptor cytosolic PI-TP, possibly similar to the one found in rat brain cytosol (58), could contribute to sustain and modulate the inositol lipid-derived signals triggered by light.

Frog and primate retinas labeled in vitro and/or in vivo with [3H]DHA display an early high level of labeling of PI, reaching values similar to that of PC and PE (29, 30, 59). In the present study, we confirm and further extend our previous observation to show that [3H]DHA-PI preferentially accumulates in the lightest fractions 1-3 of the gradient where cytosolic proteins are recovered (12), and also in ROS and in TGN fractions. The high ratio [3H]DHA-PI to [3H]DHA-PC found in TGN fractions 7-9 of frog retinas is the first evidence indicating a relative enrichment with newly synthesized [3H]DHA-PI of membranes located at the exit from the TGN compartment. As previously shown in yeast (19) and on PC12 cells (60), the high PI/PC ratio may also be essential for budding of rhodopsin-bearing vesicles from TGN and further suggests the involvement of PI/PC-TP in the dynamics of Golgi function in photoreceptors. Moreover, PI-TP has been identified as a cytosolic factor that stimulates the formation of secretory vesicles in PC12 cells (60). Since membranes recovered in TGN-enriched fractions 6-11 also contain synaptophysin, a synaptic membrane protein (12), further studies are necessary to evaluate the possible contribution of [3H]DHA-PI, in transit together with synaptophysin toward synaptic terminals, to the high [3H]DHA-PI in TGN fractions 7-9. The overall contribution of synaptic protein biosynthesis in this fraction must be relatively minor, however, since rhodopsin synthesis greatly exceeds the rate of synthesis of all other retinal membrane proteins (61).

Post-Golgi vesicles recovered from the gradient fraction 5 (rho  = 1.09 g/ml) display lower density than ROS which sediments in fractions 7-8 (rho  = 1.12-1.13) and therefore must have a higher lipid to protein ratio (12). This is also supported by freeze-fracture EM studies (62) showing that vesicles clustered around the connecting cilium display half the density of the intramembranous particle of ROS disks. Since in post-Golgi vesicles the total acyl group content, derived mainly from PLs (4.2 nmol/µg protein), was similar to that of the ROS (3.9 nmol/µg protein), other lipids such as sterols presumably contribute to their lower density. Cholesterol delivery to ROS may be accomplished either by a pathway(s) independent from that followed by integral plasma membrane proteins (18, 63) and/or together with rhodopsin and DHA-lipid-containing post-Golgi vesicles. As vesicles fuse with the plasma membrane adjacent to the base of the connecting cilium, they could generate the cholesterol-enriched domains observed in frog photoreceptors surrounding the periciliary ridge complex (64, 65) and in nascent discs at the base of the ROS (66).

In summary, this study shows that newly synthesized [3H]DHA-PLs, mainly [3H]DHA-PC and [3H]DHA-PE, are vectorially cotransported to ROS by rhodopsin-bearing post-Golgi vesicles, and other PLs such as [3H]DHA-PI may also reach ROS and the TGN by-passing the Golgi carried by transfer proteins. Moreover, in the complex process of membrane biogenesis, addition of rhodopsin and DHA-PLs at the base of ROS could be "the driving force" for the incorporation of other PLs that do not contain DHA (approximately 40-50% of total PLs in disc membranes) possibly reaching the periciliary region by independent pathways. Current studies aim to delineate the mechanism(s) that contribute to the complex polarized trafficking of DHA-PLs either by vesicular and/or by transfer protein-mediated transport to ROS.


FOOTNOTES

*   This work was supported by funding from DAMD 17-93-V-3013 (to N. G. B.) and EY 6891 (to D. S. P. and D. D.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
   To whom correspondence should be addressed: LSU Neuroscience Center, 2020 Gravier St., Suite B, New Orleans, LA 70112. Tel.: 504-568-6700 (ext. 321); Fax: 504-568-5801; E-mail: nbazan{at}lsumc.edu.
1   The abbreviations used are: ROS, rod outer segment(s); PLs, phospholipids; DHA, 22:6n-3, docosahexaenoic acid; PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine; PI, phosphatidylinositol; DAG, diacylglycerol; ER, endoplasmic reticulum; TGN, trans-Golgi network; TP, transfer proteins.
2   D. Deretic et al., manuscript in preparation.

ACKNOWLEDGEMENTS

We thank R. E. Anderson for thoughtful discussions of the results and Nilda Parkins, Belen Puleo-Scheppke, and Claudia Trippe for their excellent technical assistance.


REFERENCES

  1. Papermaster, D. S., and Dreyer, W. J. (1974) Biochemistry 13, 2438-2444 [Medline] [Order article via Infotrieve]
  2. Aveldaño de Caldironi, M. I., and Bazan, N. G. (1980) Neurochem. Int. 1, 381-392
  3. Aveldaño, M. I., and Bazan, N. G. (1983) J. Lipid Res. 24, 620-627 [Abstract/Free Full Text]
  4. Fliesler, S. J., and Anderson, R. E. (1983) Prog. Lipid Res. 22, 79-131 [CrossRef][Medline] [Order article via Infotrieve]
  5. Wiegand, R. D., and Anderson, R. E. (1983) Exp. Eye Res. 37, 150-173
  6. Choe, H.-G., and Anderson, R. E. (1990) Exp. Eye Res. 51, 159-165 [Medline] [Order article via Infotrieve]
  7. Besharse, J. C. (1986) in The Retina: A Model for Cell Biological Studies (Adler, R., and Farber, D., eds), pp. 297-352, Academic Press, Inc., New York
  8. Deretic, D., and Papermaster, D. S. (1995) in Progress in Retinal and Eye Research (Osborne, N. N., and Chadek, G. J., eds), Vol. 14, pp. 249-265, Pergamon Press Inc., Tarrytown, NY [CrossRef]
  9. Choe, H.-G., Ghalayini, A. J., and Anderson, R. E. (1990) Exp. Eye Res. 51, 167-176 [Medline] [Order article via Infotrieve]
  10. Mercurio, A. M., and Holtzman, E. (1982) J. Neurocytol. 11, 295-322 [Medline] [Order article via Infotrieve]
  11. Papermaster, D. S., Schneider, B. G., Defoe, D., and Besharse, J. C. (1986) J. Histochem. Cytochem. 34, 5-16 [Abstract]
  12. Deretic, D., and Papermaster, D. S. (1991) J. Cell Biol. 113, 1281-1293 [Abstract]
  13. Deretic, D., and Papermaster, D. S. (1993) J. Cell Sci. 106, 803-813 [Abstract/Free Full Text]
  14. Deretic, D., Aebersold, R. H., Morrison, H. D., and Papermaster, D. S. (1994) J. Biol. Chem. 269, 16853-16861 [Abstract/Free Full Text]
  15. Deretic, D., Huber, L. A., Ransom, N., Mancini, M., Simons, K., and Papermaster, D. S. (1995) J. Cell Sci. 108, 215-224 [Abstract/Free Full Text]
  16. Bishop, W. R., and Bell, R. M. (1988) Annu. Rev. Cell Biol. 4, 579-610 [CrossRef]
  17. Pagano, R. E. (1990) Curr. Opin. Cell Biol. 2, 652-663 [Medline] [Order article via Infotrieve]
  18. Voelker, D. R. (1991) Microbiol. Rev. 55, 543-560
  19. Cleves, A., McGee, T., and Bankaitis, V. (1991) Trends Cell Biol. 1, 30-34 [CrossRef]
  20. Dudley, P. A., and Anderson, R. E. (1978) FEBS Lett. 95, 57-60 [CrossRef][Medline] [Order article via Infotrieve]
  21. Sellner, P. A., Dalton, T. P., and Helmkamp, G. M. (1991) Invest. Ophthalmol. & Visual Sci. 32, Suppl. ARVO, 1149
  22. Bibb, C., and Young, R. W. (1974) J. Cell Biol. 61, 327-343 [Abstract/Free Full Text]
  23. Young, R. W. (1976) Invest. Ophthalmol. 15, 700-725
  24. Fliesler, S. J., and Basinger, S. F. (1987) J. Biol. Chem. 262, 17516-17523 [Abstract/Free Full Text]
  25. Fliesler, S. J., Florman, R., and Keller, R. K. (1995) Exp. Eye Res. 60, 57-69 [Medline] [Order article via Infotrieve]
  26. Matheke, M. L., Fliesler, S. J., Basinger, S. F., and Holtzman, E. (1984) J. Neurosci. 4, 1086-1093 [Abstract]
  27. Matheke, M. L., and Holtzman, E. (1984) J. Neurosci. 4, 1093-1103 [Abstract]
  28. Wetzel, M. G., Bendala-Tufanisco, E., and Besharse, J. C. (1993) J. Neurocytol. 22, 397-412 [Medline] [Order article via Infotrieve]
  29. Rodriguez de Turco, E. B., Gordon, W. C., and Bazan, N. G. (1991) J. Neurosci. 11, 3667-3678 [Abstract]
  30. Rodriguez de Turco, E. B., Gordon, W. C., and Bazan, N. G. (1993) Curr. Eye Res. 13, 21-28
  31. Gordon, W. C., and Bazan, N. G. (1990) J. Neurosci. 10, 2190-2202 [Abstract]
  32. Gordon, W. C., and Bazan, N. G. (1993) Invest. Ophthalmol. & Visual Sci. 34, 2402-2411 [Abstract]
  33. Deretic, D., and Papermaster, D. S. (1993) in Methods for the Study of Photoreceptor Cells (Hargrave, P., ed), Vol. 15, pp. 108-120, Rockefeller University Press, New York
  34. Louie, K., Wiegand, R. D., and Anderson, R. E. (1988) Biochemistry 27, 9014-9020 [Medline] [Order article via Infotrieve]
  35. Bazan, N. G. (1982) in Phospholipids in the Nervous System (Horrocks, L. A., Ansell, G. B., and Porcellati, G., eds), pp. 49-62, Raven Press, NY
  36. Bazan, N. G., Reddy, T. S., Bazan, H. E. P., and Birkle, D. L. (1986) Prog. Lipid Res. 25, 595-606 [CrossRef][Medline] [Order article via Infotrieve]
  37. Rotstein, N. P., and Aveldaño, M. I. (1987) Biochim. Biophys. Acta 921, 221-234 [Medline] [Order article via Infotrieve]
  38. Rotstein, N. P., and Aveldaño, M. I. (1987) Biochim. Biophys. Acta 921, 235-244 [Medline] [Order article via Infotrieve]
  39. Rodriguez de Turco, E. B., Gordon, W. C., and Bazan, N. G. (1992) Invest. Ophthalmol. & Visual Sci. 32, Suppl. ARVO, 702
  40. Fanger, B. O. (1987) Anal. Biochem. 162, 11-17 [Medline] [Order article via Infotrieve]
  41. Folch, J., Lees, M., and Stanley, G. H. S. (1957) J. Biol. Chem. 226, 497-509 [Free Full Text]
  42. Marcheselli, V. L., and Bazan, N. G. (1990) J. Nutr. Biochem. 1, 231-237
  43. Deretic, D., Puleo-Scheppke, B., and Trippe, C. (1996) J. Biol. Chem. 271, 2279-2286 [Abstract/Free Full Text]
  44. Roque, M. E., and Giusto, N. M. (1995) Exp. Eye Res. 60, 631-643 [Medline] [Order article via Infotrieve]
  45. Jiao, X., Gentleman, S., Wetzel, M. G., O'Brien, P., and Chader, G. F. (1993) Invest. Ophthalmol. & Visual Sci. 34, (suppl.) 1328
  46. Sellner, P. (1994) Invest. Ophthalmol. & Visual Sci. 35, 443-452 [Abstract]
  47. Lee, J., Jiao, X., Gentleman, S., Wetzel, M. G., O'Brien, P., and Chader, G. F. (1995) Invest. Ophthalmol. & Visual Sci. 36, 2032-2039 [Abstract]
  48. Reddy, T. S., and Bazan, N. G. (1984) Curr. Eye Res. 3, 1225-1232 [Medline] [Order article via Infotrieve]
  49. Giusto, N. M., Boschero, M. I., Sprecher, H., and Aveldaño, M. I. (1986) Biochim. Biophys. Acta 860, 137-148 [Medline] [Order article via Infotrieve]
  50. Zimmerman, W. F., and Keys, S. (1988) Exp. Eye Res. 47, 247-260 [Medline] [Order article via Infotrieve]
  51. Louie, K., Zimmerman, W. F., Keys, S., and Anderson, R. E. (1991) Exp. Eye Res. 53, 309-316 [Medline] [Order article via Infotrieve]
  52. Bazan, N. G. (1990) Nutrition and the Brain, pp. 1-24, Raven Press, Ltd, New York
  53. Chen, Y. S., and Hubbel, W. L. (1973) Exp. Eye Res. 17, 517-532 [Medline] [Order article via Infotrieve]
  54. Aveldaño, M. I. (1988) Biochemistry 27, 1229-1239 [Medline] [Order article via Infotrieve]
  55. Giusto, N. M., and Ilincheta de Boschero, M. G. (1986) Biochim. Biophys. Acta 877, 440-446 [Medline] [Order article via Infotrieve]
  56. Ghalayini, A. J., and Anderson, R. E. (1984) Biochem. Biophys. Res. Commun. 124, 503-506 [Medline] [Order article via Infotrieve]
  57. Ghalayini, A. J., and Anderson, R. E. (1992) J. Biol. Chem. 267, 17977-17982 [Abstract/Free Full Text]
  58. Thomas, G. M. H., Cunningham, E., Fensome, A., Ball, A., Totty, N. F., Troung, O., et al. (1993) Cell 74, 919-928 [Medline] [Order article via Infotrieve]
  59. Rodriguez de Turco, E. B., Gordon, W. C., Peyman, G. A., and Bazan, N. G. (1990) J. Neurosci. Res. 27, 522-532 [Medline] [Order article via Infotrieve]
  60. Ohashi, M., de Vries, K. J., Frank, R., Snoek, G., Bankaitis, V., Wirtz, K., and Hutter, W. B. (1995) Nature 377, 544-547 [CrossRef][Medline] [Order article via Infotrieve]
  61. Papermaster, D. S., Converse, C. A., and Siu, J. (1975) Biochemistry 14, 1343-1352 [Medline] [Order article via Infotrieve]
  62. Besharse, J. C., and Pfenninger, K. H. (1980) J. Cell Biol. 87, 451-463 [Abstract]
  63. Urbani, L., and Simoni, R. D. (1990) J. Biol. Chem. 265, 1919-1923 [Abstract/Free Full Text]
  64. Andrews, L. D., and Cohen, A. I. (1981) Exp. Eye Res. 33, 1-10 [Medline] [Order article via Infotrieve]
  65. Andrews, L. D., and Cohen, A. I. (1983) J. Cell Biol. 97, 749-755 [Abstract]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.